High efficiency protein transduction of quiescent and proliferating primary hematopoietic cells

Journal of Biochemical and Biophysical Methods

Volumn 55, Issue 3, 2003, Pages 251-258

  Lea, Nicholas C ^a   Buggins, Andrea G S ^a   Orr, Stephen J ^a   Mufti, Ghulam J ^a   Thomas, N Shaun B ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

AML; Hematopoietic stem cell transfection; Protein transduction; TAT

Indexed keywords

CD34 ANTIGEN; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; TRANSACTIVATOR PROTEIN; VIRUS PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; AMINO ACID SEQUENCE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; DENDRITIC CELL; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; GRANULOCYTE; HEMATOPOIETIC CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MONOCYTE; MYELOBLAST; PRIORITY JOURNAL; PROTEIN DOMAIN; T LYMPHOCYTE; TECHNIQUE;

EID: 0037471140     PISSN: 0165022X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-022X(03)00077-0     Document Type: Article

References (22)

1. Zhu Y.M., Bradbury D.A., Keith F.J., Russell N. Absence of retinoblastoma protein expression results in autocrine production of interleukin-6 and promotes the autonomous growth of acute myeloid leukemia blast cells. Leukemia. 8(11):1994;1982-1988.
2. Williams C.D., Linch D.C., Watts M.J., Thomas N.S. Characterization of cell cycle status and E2F complexes in mobilized CD34+ cells before and after cytokine stimulation. Blood. 90(1):1997;194-203.
3. Glimm H., Oh I.H., Eaves C.J. Human hematopoietic stem cells stimulated to proliferate in vitro lose engraftment potential during their S/G(2)/M transit and do not reenter G(0). Blood. 96(13):2000;4185-4193.
4. Roddie P.H., Paterson T., Turner M.L. Gene transfer to primary acute myeloid leukaemia blasts and myeloid leukaemia cell lines. Cytokines Cell Mol. Ther. 6(3):2000;127-134.
5. Lea N.C., Buggins A.G.S., Hirst W.J.R., Gaken J., Farzaneh F., Mufti G.J. Gene expression using adenoviral vectors in primary acute myeloid leukaemia cells. Blood. 94(10):1999;413b.
6. Park F., Ohashi K., Chiu W., Naldini L., Kay M.A. Efficient lentiviral transduction of liver requires cell cycling in vivo. Nat. Genet. 24(1):2000;49-52.
7. Frankel A.D., Pabo C.O. Cellular uptake of the tat protein from human immunodeficiency virus. Cell. 55(6):1988;1189-1193.
8. Wadia J.S., Dowdy S.F. Protein transduction technology. Curr. Opin. Biotechnol. 13(1):2002;52-56.
9. Joliot A., Pernelle C., Deagostini-Basin H., Prochiantz A. Antennapedia homeobox peptide regulates neural morphogenesis. Proc. Natl. Acad. Sci. U. S. A. 88(5):1991;1864-1868.
10. Elliott G., O'Hare P. Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell. 88(2):1997;223-233.
11. Schwarze S.R., Ho A., Vocero-Akbani A., Dowdy S.F. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science. 285(5433):1999;1569-1572.
12. Banerji L., Glassford J., Lea N.C., Thomas N.S., Klaus G.G., Lam E.W.-F. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells. Oncogene. 20(50):2001;7352-7367.
13. Parada Y., Banerji L., Glassford J., Lea N.C., Collado M., Rivas C.et al. BCR-ABL and interleukin 3 promote haematopoietic cell proliferation and survival through modulation of cyclin D2 and p27Kip1 expression. J. Biol. Chem. 276(26):2001;23572-23580.
14. Ho A., Schwarze S.R., Mermelstein S.J., Waksman G., Dowdy S.F. Synthetic protein transduction domains: enhanced transduction potential in vitro and in vivo. Cancer Res. 61(2):2001;474-477.
15. Wender P.A., Mitchell D.J., Pattabiraman K., Pelkey E.T., Steinman L., Rothbard J.B. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc. Natl. Acad. Sci. U. S. A. 97(24):2000;13003-13008.
16. Devalia V., Thomas N.S., Roberts P.J., Jones H.M., Linch D.C. Down-regulation of human protein kinase C alpha is associated with terminal neutrophil differentiation. Blood. 80(1):1992;68-76.
17. Darzynkiewicz Z., Traganos F., Melamed M.R. New cell cycle compartments identified by multiparameter flow cytometry. Cytometry. 1(2):1980;98-108.
18. Thomas N.S., Pizzey A.R., Tiwari S., Williams C.D., Yang J. p130, p107, and pRb are differentially regulated in proliferating cells and during cell cycle arrest by alpha-interferon. J. Biol. Chem. 273(37):1998;23659-23667.
19. Nagahara H., Vocero-Akbani A.M., Snyder E.L., Ho A., Latham D.G., Lissy N.A.et al. Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat. Med. 4(12):1998;1449-1452.
20. Gius D.R., Ezhevsky S.A., Becker-Hapak M., Nagahara H., Wei M.C., Dowdy S.F. Transduced p16INK4a peptides inhibit hypophosphorylation of the retinoblastoma protein and cell cycle progression prior to activation of Cdk2 complexes in late G1. Cancer Res. 59(11):1999;2577-2580.
21. Ezhevsky S.A., Ho A., Becker-Hapak M., Davis P.K., Dowdy S.F. Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo. Mol. Cell Biol. 21(14):2001;4773-4784.
22. Wang H.Y., Fu T., Wang G., Zeng G., Perry-Lalley D.M., Yang J.C.et al. Induction of CD4(+) T cell-dependent antitumor immunity by TAT-mediated tumor antigen delivery into dendritic cells. J. Clin. Invest. 109(11):2002;1463-1470.